Prostate Cancer - Results from #23600

Modeling of the bony pelvis from MRI using a multi-atlas AE-SDM for registration and tracking in image-guided robotic prostatectomy - Abstract March 29, 2013

Comparison of image-guided radiotherapy technologies for prostate cancer - Abstract March 29, 2013

Imaging evaluation of prostate cancer with (18)F-fluorodeoxyglucose PET/CT: Utility and limitations - Abstract March 29, 2013

Does obesity affect the accuracy of prostate-specific antigen (PSA) for predicting prostate cancer among men undergoing prostate biopsy - Abstract March 29, 2013

Prostate cancer detection rate at repeat saturation biopsy: PCPT risk calculator versus PCA3 score versus case-finding protocol - Abstract March 29, 2013

Ejaculation profiles of men following radiation therapy for prostate cancer - Abstract March 29, 2013

Magnetic resonance imaging (MRI) markers for MRI-guided high-dose-rate brachytherapy: Novel marker-flange for cervical cancer and marker catheters for prostate cancer - Abstract March 29, 2013

Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: A Nationwide Danish population-based cohort study - Abstract March 29, 2013

Imaging of castration-resistant prostrate cancer: Development of imaging response biomarkers - Abstract March 28, 2013

Population-based study on use of chemotherapy in men with castration resistant prostate cancer - Abstract March 28, 2013

Active surveillance: Oncologic outcome - Abstract March 28, 2013

Solitary lung metastasis after radical prostatectomy in presence of undetectable PSA - Abstract March 28, 2013

PCA3 score accuracy in diagnosing prostate cancer at repeat biopsy: Our experience in 177 patients - Abstract March 28, 2013

Transrectal ultrasound (TRUS) and TRUS-biopsy accuracy in potential candidates for PRIAS active surveillance protocol - Abstract March 28, 2013

Androgen-deprivation therapy and risk for biliary disease in men with prostate cancer - Abstract March 28, 2013

Course of the type of patient who is candidate for radical prostatectomy over 2 decades (1989-2009) - Abstract March 28, 2013

Relationship of early-onset baldness to prostate cancer in African-American men - Abstract March 28, 2013

EDAP receives U.S. FDA filing acceptance of pre-market approval application March 28, 2013

Urological medical oncology: Land of opportunity - Abstract March 28, 2013

Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer - Abstract March 27, 2013

Page 1181 of 1439